About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
EGRX - Eagle Pharmaceutical...| Previous Close | $48.08 | Open | $48.14 |
| Volume | 95.1K | Market Cap | 700.21M |
| Yield | Last Dividend |
| Eagle Pharmaceuticals Announces Update i... | 01/11/21 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that, on January ... | |
| Eagle Pharmaceuticals to Present at the ... | 01/04/21 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals??? Presentation at... | 11/23/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that the Company?... | |
| Eagle Pharmaceuticals Inc. (EGRX) Q3 202... | 11/02/20 |
| Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson ??? Investor Relations ??? ... | |
| Earnings Scheduled For November 2, 2020 | 11/02/20 |
| Companies Reporting Before The Bell ??? Itron (NASDAQ: ITRI ) is likely to report quarterly earnings at $0.25 per share on revenue of $540.01 million.... | |
| Eagle Pharmaceuticals Reports Third Quar... | 11/02/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced financial results... | |
| The Week Ahead In Biotech (Nov. 1-7): Ad... | 11/01/20 |
| Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and macroeconomic conce... | |
| Eagle Pharmaceuticals to Discuss Third Q... | 10/26/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (Nasdaq: EGRX) today announced that the Company ... | |
| Eagle Pharmaceuticals (NASDAQ:EGRX) Rati... | 10/24/20 |
| Eagle Pharmaceuticals (NASDAQ:EGRX) was upgraded by BidaskClub from a ???buy??? rating to a ???strong-buy??? rating in a research report issued to cli... | |
| Eagle Pharmaceuticals Inc (NASDAQ:EGRX) ... | 10/23/20 |
| Equities research analysts expect that Eagle Pharmaceuticals Inc (NASDAQ:EGRX) will announce $46.31 million in sales for the current fiscal quarter, a... | |
| Eagle Pharmaceuticals (NASDAQ:EGRX) Upgr... | 10/23/20 |
| BidaskClub upgraded shares of Eagle Pharmaceuticals (NASDAQ:EGRX) from a buy rating to a strong-buy rating in a research note issued to investors on T... | |
| Eagle Pharmaceuticals Inc (NASDAQ:EGRX) ... | 10/20/20 |
| Eagle Pharmaceuticals Inc (NASDAQ:EGRX) saw a significant increase in short interest in September. As of September 30th, there was short interest tota... | |
| Eagle Pharmaceuticals??? Japanese Licens... | 09/23/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today announced that its marketin... | |
| Eagle Pharmaceuticals to Present at Upco... | 09/08/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals Announces Publicat... | 08/19/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that preclinical ... | |
| The Week Ahead In Biotech: Spotlight On ... | 08/16/20 |
| Biotech stocks came under pressure in the week ended Aug. 14 amid mixed earnings news flow from the sector. FDA decisions scheduled for the week also ... | |
| Eagle Pharmaceuticals Reports Second Qua... | 08/10/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced financial results... | |
| Earnings Scheduled For August 10, 2020 | 08/10/20 |
| Companies Reporting Before The Bell ??? Acacia Research Inc. (NASDAQ: ACTG ) is expected to report quarterly loss at $0.02 per share on revenue of $20... | |
| The Week Ahead In Biotech: Bausch Health... | 08/09/20 |
| Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and c... | |
| Eagle Pharmaceuticals to Discuss Second ... | 08/03/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (Nasdaq: EGRX) today announced that the Company ... | |
| The Week Ahead In Biotech: Novavax Coron... | 08/02/20 |
| Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flo... | |
| Attention Biotech Investors: Mark Your C... | 07/31/20 |
| July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP ) cellulite treatment, Osmotica Pharmaceuticals PLC's (N... | |
| The Week Ahead In Biotech: Endo, Eagle P... | 07/06/20 |
| Biotech stocks rebounded in the holiday-shortened week ending July 2 as investors reacted to pending clinical trial readouts and the news flow surroun... | |
| Eagle Pharmaceuticals to Present at June... | 05/26/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals Announces Change t... | 05/22/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle???) announced today that, due to public health and safety ... | |
| Eagle Pharmaceuticals to Present at the ... | 05/12/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals (EGRX) Q1 Earnings... | 05/11/20 |
| Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 78.72% and -3.63%, respectively, for the quarter ended March 2020. Do the num... | |
| Fed Circuit okays generic version of Eag... | 05/08/20 |
| Generic drug company Slayback Pharma LLC on Friday won an appeals court decision that clears the way for it to launch a generic version of the Eagle P... | |
| Why Eagle Pharmaceuticals (EGRX) Might S... | 05/08/20 |
| Eagle Pharmaceuticals (EGRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings seaso... | |
| Eagle Pharmaceuticals Advances Novel and... | 05/04/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today provided an update on its p... | |
| Date | 2020-11-02 (BMO) | Est. (EPS/Rev.) | $0.28/ 47.02M |
| Actual (EPS/Rev.) | $1.17/ $49.93 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
